These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 22723560)
21. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. Grundy SM J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636 [TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome: at the crossroads of cardiorenal risk. Natali A; Pucci G; Boldrini B; Schillaci G J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816 [TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage. Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751 [TBL] [Abstract][Full Text] [Related]
24. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
25. Obesity and the metabolic syndrome in the elderly--a mini-review. Lechleitner M Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025 [TBL] [Abstract][Full Text] [Related]
26. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Ahmed I; Goldstein BJ Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936 [TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome: implications of race and ethnicity. Mugo M; Sowers JR Ethn Dis; 2004; 14(4):S2-26-31. PubMed ID: 15724794 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events. Zarich SW Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015 [TBL] [Abstract][Full Text] [Related]
30. The metabolic syndrome and its cardiovascular manifestations. Sánchez-Torres RJ; Delgado-Osorio H Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068 [TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome: are we at risk? Paudel B Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442 [TBL] [Abstract][Full Text] [Related]
32. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468 [TBL] [Abstract][Full Text] [Related]
33. The metabolic syndrome - an ongoing story. Duvnjak L; Duvnjak M J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():19-24. PubMed ID: 20388942 [TBL] [Abstract][Full Text] [Related]
34. Cardiovascular molecular MR imaging. Lamb HJ; van der Meer RW; de Roos A; Bax JJ Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1(Suppl 1):S99-104. PubMed ID: 17505824 [TBL] [Abstract][Full Text] [Related]
35. The progression of cardiovascular risk to cardiovascular disease. Rosin BL Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392 [TBL] [Abstract][Full Text] [Related]
36. A review of the metabolic syndrome. Balkau B; Valensi P; Eschwège E; Slama G Diabetes Metab; 2007 Dec; 33(6):405-13. PubMed ID: 17981485 [TBL] [Abstract][Full Text] [Related]
38. Arterial function in cardio-metabolic diseases: from the microcirculation to the large conduits. Chantler PD; Frisbee JC Prog Cardiovasc Dis; 2015; 57(5):489-96. PubMed ID: 25220256 [TBL] [Abstract][Full Text] [Related]
39. [Metabolic and cardiovascular effects of physical activity, exercise and fitness in patients with type 2 diabetes]. Blüher M; Zimmer P Dtsch Med Wochenschr; 2010 May; 135(18):930-4. PubMed ID: 20425681 [TBL] [Abstract][Full Text] [Related]
40. [Metabolic syndrome: a common soil for diseases]. Chen JW Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):161-2. PubMed ID: 15840248 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]